Skip to content

A Prospective Study of Gall Bladder Cancer Patients

A Prospective Observational Study of Gall Bladder Cancer Patients Presenting in a Tertiary Care Centre. - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/057126
Enrollment
3000
Registered
2023-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C23- Malignant neoplasm of gallbladder

Interventions

Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

MAHAMANA PANDIT MADAN MOHAN MALAVIYA CANCER CENTRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Gall Bladder cancer patients who get registered at study site.

Exclusion criteria

Exclusion criteria: Patients unwilling to participate in study

Design outcomes

Primary

MeasureTime frame
To assess overall survival (OS) & disease-free survival (DFS) of Gall Bladder Cancer patientsTimepoint: At one year

Secondary

MeasureTime frame
To assess response rate to neoadjuvant chemotherapy in Gall Bladder Cancer patientsTimepoint: At One Year;To study the demographic profile of Gall Baldder Cancer patientsTimepoint: NOT APPLICABLE;To study the impact of patients socioeconomic status on disease outcomes in Gall Bladder Cancer patientsTimepoint: At One Year;To study the impact of obstructive jaundice on outcomes in Gall Bladder Cancer patientsTimepoint: At one year

Countries

India

Contacts

Public ContactKumar Vineet

Mahamana Pandit Madan Mohan Malaviya Cancer Centre

drswapnilpatel01@gmail.com7777051458

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026